L-asparaginase has become an integral part in the treatment of acute lymphoblastic leukemia. The major worry of using L-asparaginase is thromboembolism. The case presented here is a 21-year-old lady who developed fatal cortical venous thrombosis during induction phase of treatment for ALL. Early recognition is very important to treat this potentially catastrophic yet treatable complication.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452943 | PMC |
http://dx.doi.org/10.1007/s12288-010-0005-7 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!